Concepts (142)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Whooping Cough | 2 | 2020 | 4 | 1.050 |
Why?
|
| Bacteria | 4 | 2018 | 245 | 0.890 |
Why?
|
| Bordetella parapertussis | 1 | 2020 | 1 | 0.780 |
Why?
|
| Bordetella pertussis | 1 | 2020 | 2 | 0.780 |
Why?
|
| Nasopharynx | 1 | 2020 | 6 | 0.780 |
Why?
|
| Proteomics | 3 | 2007 | 302 | 0.750 |
Why?
|
| Calcium Signaling | 2 | 2014 | 95 | 0.730 |
Why?
|
| Calcium-Binding Proteins | 2 | 2014 | 72 | 0.680 |
Why?
|
| Clinical Laboratory Techniques | 2 | 2007 | 22 | 0.600 |
Why?
|
| Hospitals, Animal | 1 | 2016 | 1 | 0.590 |
Why?
|
| Veterinary Medicine | 1 | 2016 | 3 | 0.590 |
Why?
|
| Equipment Contamination | 1 | 2016 | 5 | 0.590 |
Why?
|
| Disinfectants | 1 | 2016 | 7 | 0.590 |
Why?
|
| Disinfection | 1 | 2016 | 8 | 0.580 |
Why?
|
| Neisseria meningitidis | 4 | 2022 | 16 | 0.550 |
Why?
|
| Prokaryotic Cells | 1 | 2014 | 8 | 0.520 |
Why?
|
| Paper | 4 | 2017 | 22 | 0.420 |
Why?
|
| Lab-On-A-Chip Devices | 4 | 2022 | 32 | 0.390 |
Why?
|
| Helicobacter Infections | 4 | 2012 | 74 | 0.370 |
Why?
|
| Anti-Bacterial Agents | 4 | 2018 | 355 | 0.370 |
Why?
|
| Bacterial Typing Techniques | 2 | 2020 | 34 | 0.360 |
Why?
|
| Biosensing Techniques | 4 | 2018 | 81 | 0.320 |
Why?
|
| Streptococcus pneumoniae | 2 | 2017 | 28 | 0.300 |
Why?
|
| Bacterial Infections | 1 | 2007 | 44 | 0.290 |
Why?
|
| Helicobacter pylori | 4 | 2012 | 105 | 0.290 |
Why?
|
| Aptamers, Nucleotide | 2 | 2018 | 28 | 0.280 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2018 | 32 | 0.280 |
Why?
|
| Pertussis Vaccine | 1 | 2005 | 2 | 0.260 |
Why?
|
| Graphite | 2 | 2017 | 50 | 0.260 |
Why?
|
| Histiocytic Necrotizing Lymphadenitis | 1 | 2003 | 3 | 0.230 |
Why?
|
| Herpesvirus 6, Human | 1 | 2003 | 4 | 0.230 |
Why?
|
| Genetic Techniques | 1 | 2003 | 15 | 0.230 |
Why?
|
| Serologic Tests | 1 | 2003 | 43 | 0.220 |
Why?
|
| Communicable Diseases | 1 | 2022 | 42 | 0.210 |
Why?
|
| Calcium | 1 | 2004 | 445 | 0.210 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2018 | 57 | 0.190 |
Why?
|
| Humans | 17 | 2022 | 34853 | 0.190 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 47 | 0.190 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 628 | 0.190 |
Why?
|
| DNA, Bacterial | 2 | 2017 | 184 | 0.180 |
Why?
|
| Bacillus subtilis | 1 | 1999 | 13 | 0.180 |
Why?
|
| Microfluidics | 2 | 2022 | 39 | 0.180 |
Why?
|
| Calmodulin | 1 | 1999 | 41 | 0.170 |
Why?
|
| Furosemide | 1 | 2018 | 9 | 0.170 |
Why?
|
| Nanocomposites | 1 | 2018 | 19 | 0.170 |
Why?
|
| Penicillanic Acid | 1 | 2018 | 2 | 0.160 |
Why?
|
| Cephalosporins | 1 | 2018 | 3 | 0.160 |
Why?
|
| Escherichia coli | 2 | 2018 | 436 | 0.160 |
Why?
|
| Pilot Projects | 3 | 2016 | 628 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2018 | 62 | 0.160 |
Why?
|
| Silver | 1 | 2018 | 53 | 0.160 |
Why?
|
| beta-Lactamases | 1 | 2018 | 33 | 0.160 |
Why?
|
| Polymethyl Methacrylate | 1 | 2017 | 14 | 0.160 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2018 | 30 | 0.160 |
Why?
|
| DNA Probes | 1 | 2017 | 26 | 0.160 |
Why?
|
| Dimethylpolysiloxanes | 2 | 2014 | 14 | 0.160 |
Why?
|
| Neoplasms | 1 | 2007 | 1033 | 0.150 |
Why?
|
| Meningitis, Meningococcal | 1 | 2016 | 3 | 0.150 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 2 | 2007 | 79 | 0.150 |
Why?
|
| Haemophilus influenzae | 1 | 2016 | 5 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2017 | 298 | 0.140 |
Why?
|
| Nanostructures | 1 | 2017 | 133 | 0.140 |
Why?
|
| Meningitis, Bacterial | 1 | 2014 | 8 | 0.130 |
Why?
|
| Bacterial Proteins | 1 | 1999 | 520 | 0.130 |
Why?
|
| Iron, Dietary | 2 | 2011 | 13 | 0.130 |
Why?
|
| Protein Structure, Secondary | 1 | 2014 | 172 | 0.120 |
Why?
|
| Nanoparticles | 1 | 2018 | 294 | 0.120 |
Why?
|
| Animals | 4 | 2016 | 14307 | 0.120 |
Why?
|
| Bismuth | 1 | 2012 | 3 | 0.110 |
Why?
|
| Limit of Detection | 3 | 2018 | 56 | 0.110 |
Why?
|
| Nanotechnology | 1 | 2013 | 150 | 0.110 |
Why?
|
| Ferritins | 1 | 2011 | 54 | 0.100 |
Why?
|
| Child | 4 | 2011 | 2875 | 0.080 |
Why?
|
| Point-of-Care Systems | 2 | 2018 | 26 | 0.080 |
Why?
|
| Feces | 1 | 2008 | 110 | 0.080 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2018 | 203 | 0.080 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 129 | 0.080 |
Why?
|
| Isoelectric Focusing | 1 | 2007 | 16 | 0.080 |
Why?
|
| Microbiological Techniques | 1 | 2007 | 11 | 0.080 |
Why?
|
| Pneumococcal Infections | 2 | 2017 | 27 | 0.070 |
Why?
|
| Equipment Design | 2 | 2017 | 127 | 0.070 |
Why?
|
| Drug Therapy, Combination | 3 | 2012 | 217 | 0.070 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 100 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 129 | 0.070 |
Why?
|
| Oxides | 2 | 2017 | 89 | 0.060 |
Why?
|
| Prognosis | 1 | 2007 | 707 | 0.060 |
Why?
|
| Amphotericin B | 1 | 2003 | 24 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 275 | 0.060 |
Why?
|
| Lymphadenitis | 1 | 2003 | 3 | 0.060 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 445 | 0.060 |
Why?
|
| Coccidioidomycosis | 1 | 2003 | 46 | 0.060 |
Why?
|
| Homeostasis | 1 | 2004 | 172 | 0.060 |
Why?
|
| Treatment Outcome | 3 | 2012 | 1349 | 0.060 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2022 | 28 | 0.060 |
Why?
|
| Antifungal Agents | 1 | 2003 | 147 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2011 | 1318 | 0.050 |
Why?
|
| Adult | 3 | 2012 | 11034 | 0.050 |
Why?
|
| Female | 6 | 2018 | 19873 | 0.050 |
Why?
|
| Intention to Treat Analysis | 2 | 2011 | 11 | 0.050 |
Why?
|
| Breath Tests | 2 | 2012 | 24 | 0.050 |
Why?
|
| Male | 6 | 2012 | 18870 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2011 | 269 | 0.050 |
Why?
|
| Texas | 2 | 2012 | 299 | 0.050 |
Why?
|
| Middle Aged | 3 | 2018 | 9642 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2014 | 555 | 0.050 |
Why?
|
| Microscopy, Immunoelectron | 1 | 1999 | 34 | 0.050 |
Why?
|
| Dietary Supplements | 2 | 2011 | 196 | 0.040 |
Why?
|
| Food Microbiology | 1 | 2018 | 34 | 0.040 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2018 | 138 | 0.040 |
Why?
|
| Liver Abscess | 1 | 2018 | 3 | 0.040 |
Why?
|
| Time Factors | 2 | 2013 | 1681 | 0.040 |
Why?
|
| Meningococcal Infections | 1 | 2017 | 3 | 0.040 |
Why?
|
| Cattle | 1 | 1999 | 472 | 0.040 |
Why?
|
| Staphylococcus aureus | 1 | 2018 | 80 | 0.040 |
Why?
|
| Cell Membrane | 1 | 1999 | 360 | 0.040 |
Why?
|
| Blotting, Western | 1 | 1999 | 834 | 0.040 |
Why?
|
| Haemophilus Infections | 1 | 2016 | 3 | 0.040 |
Why?
|
| Metal Nanoparticles | 1 | 2018 | 180 | 0.030 |
Why?
|
| Polymers | 1 | 2016 | 117 | 0.030 |
Why?
|
| Adolescent | 1 | 2005 | 5035 | 0.030 |
Why?
|
| Glass | 1 | 2013 | 15 | 0.030 |
Why?
|
| Calibration | 1 | 2013 | 55 | 0.030 |
Why?
|
| Omeprazole | 1 | 2012 | 6 | 0.030 |
Why?
|
| Metronidazole | 1 | 2012 | 13 | 0.030 |
Why?
|
| Tetracycline | 1 | 2012 | 17 | 0.030 |
Why?
|
| Urea | 1 | 2012 | 42 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2012 | 212 | 0.030 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2011 | 20 | 0.020 |
Why?
|
| Reference Values | 1 | 2011 | 204 | 0.020 |
Why?
|
| Species Specificity | 1 | 2011 | 233 | 0.020 |
Why?
|
| Carbon Isotopes | 1 | 2008 | 38 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2008 | 105 | 0.020 |
Why?
|
| Catalase | 1 | 2008 | 106 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 6448 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2008 | 232 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2008 | 901 | 0.020 |
Why?
|
| Infant | 1 | 2008 | 1014 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2008 | 1422 | 0.020 |
Why?
|
| Fluconazole | 1 | 2003 | 41 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1425 | 0.010 |
Why?
|
| Liposomes | 1 | 2003 | 107 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2008 | 1961 | 0.010 |
Why?
|